Fulgent Genetics Inc
FLGT
Get informed when a big investor buys or sells
+ FollowMarket Cap$515.19M
Close$
$7.80
57% downside
Current Fair Value
57% downsideOvervalued by 57% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $515.19 Million |
|---|---|
| Enterprise Value | $504.96 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.97 |
| Beta | 0.88 |
| Outstanding Shares | 30,881,000 |
Return
| Return on Equity | -7.03% |
|---|---|
| Return on Assets | -6.38% |
| Return on Invested Capital | -8.55% |
Valuation & Multiples
| P/E Ratio | -7.59 |
|---|---|
| PEG | -6.58 |
| Price to Sales | 1.81 |
| Price to Book Ratio | 0.55 |
| Enterprise Value to Revenue | 1.58 |
| Enterprise Value to EBIT | -5.54 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 1, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$68.09 M
Average shareholder expectationNext Earnings Call
Expected Date
July 31, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$94.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4154▲ 17.95% |
|---|---|
| Total Calls | 60,900▼ 23.97% |
| Total Puts | 25,300▲ 33.86% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 56.70%▼ 1.35% |
|---|---|
| Total Invested | $277.46M▼ 40.83% |
| Investors Holding | 160▼ 23.00% |
ESG Score
No data
About Fulgent Genetics Inc
429 employees
CEO: Ming Hsieh Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and...